EU inspectors tap CDISC in GCP guidance

Twelve user requirements for source data developed by CDISC form the basis of the European Union's expectations for the handling of electronic data in clinical trials. The principles embodied in the 12 requirements, detailed in the CDISC Standards and Electronic Source Data within Clinical Trials, 20 November 2006, "provide a good basis for the acceptability of source data," according to the EU's reflection paper, and therefore represent good clinical practice.

The EU GCP Inspectors Working Group has sorted the 12 tenets into five topics: system creation and modification; data creation, modification and transfer; source document control; copying; and storage. The document represents the current expectations of GCP inspectors: "Any departure would need to be justified."

Ultimately, "integrity of data must be confirmable," the document says. To protect patient safety, all data must be available to the investigator. Data held by the sponsor should be verifiable by a copy held elsewhere.

- see the paper

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.